Moderna enrolls final volunteers into key coronavirus vaccine study
Excerpt from the Article:
When Moderna began research on a vaccine for the virus now known as SARS-CoV-2 in late January, confirmed cases of infection were largely contained within China and the public health catastrophe that’s since unfolded was a threat, not reality.
The prospect of designing, testing, and proving a vaccine within a year — a timeline never before achieved — was similarly remote.
Moderna has yet to accomplish that goal, with the trial that’s now fully enrolled being the crucial test of whether its vaccine can prevent coronavirus disease or infection. But the progress it and others have made to get to this point is still a scientific achievement with few modern parallels.
Click the button below to continue reading the Article:
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?